Thomas WG - Search Results

1

Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.

Callander GE, Thomas WG, Bathgate RA. Callander GE, et al. Among authors: thomas wg. Am J Physiol Cell Physiol. 2009 May;296(5):C1058-66. doi: 10.1152/ajpcell.00581.2008. Epub 2009 Mar 11. Am J Physiol Cell Physiol. 2009. PMID: 19279230 Free article.

2

Development and optimization of microRNA against relaxin-3.

Callander GE, Thomas WG, Bathgate RA. Callander GE, et al. Among authors: thomas wg. Ann N Y Acad Sci. 2009 Apr;1160:261-4. doi: 10.1111/j.1749-6632.2008.03816.x. Ann N Y Acad Sci. 2009. PMID: 19416200

3

Silencing relaxin-3 in nucleus incertus of adult rodents: a viral vector-based approach to investigate neuropeptide function.

Callander GE, Ma S, Ganella DE, Wimmer VC, Gundlach AL, Thomas WG, Bathgate RA. Callander GE, et al. Among authors: thomas wg. PLoS One. 2012;7(8):e42300. doi: 10.1371/journal.pone.0042300. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876314 Free PMC article.

4

Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis.

Bathgate RA, Lekgabe ED, McGuane JT, Su Y, Pham T, Ferraro T, Layfield S, Hannan RD, Thomas WG, Samuel CS, Du XJ. Bathgate RA, et al. Among authors: thomas wg. Mol Cell Endocrinol. 2008 Jan 2;280(1-2):30-8. doi: 10.1016/j.mce.2007.09.008. Epub 2007 Sep 22. Mol Cell Endocrinol. 2008. PMID: 17961912

5

Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.

Qian H, Pipolo L, Thomas WG. Qian H, et al. Among authors: thomas wg. Mol Endocrinol. 2001 Oct;15(10):1706-19. doi: 10.1210/mend.15.10.0714. Mol Endocrinol. 2001. PMID: 11579203

6

Helix I of beta-arrestin is involved in postendocytic trafficking but is not required for membrane translocation, receptor binding, and internalization.

Dinh DT, Qian H, Seeber R, Lim E, Pfleger K, Eidne KA, Thomas WG. Dinh DT, et al. Among authors: thomas wg. Mol Pharmacol. 2005 Feb;67(2):375-82. doi: 10.1124/mol.104.004721. Epub 2004 Nov 2. Mol Pharmacol. 2005. PMID: 15523053

7

Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles.

Porrello ER, Pfleger KD, Seeber RM, Qian H, Oro C, Abogadie F, Delbridge LM, Thomas WG. Porrello ER, et al. Among authors: thomas wg. Cell Signal. 2011 Nov;23(11):1767-76. doi: 10.1016/j.cellsig.2011.06.011. Epub 2011 Jun 25. Cell Signal. 2011. PMID: 21740964

8

Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ, Thomas WG. Holloway AC, et al. Among authors: thomas wg. Mol Pharmacol. 2002 Apr;61(4):768-77. doi: 10.1124/mol.61.4.768. Mol Pharmacol. 2002. PMID: 11901215

9

Type 1 angiotensin receptor pharmacology: signaling beyond G proteins.

Oro C, Qian H, Thomas WG. Oro C, et al. Among authors: thomas wg. Pharmacol Ther. 2007 Jan;113(1):210-26. doi: 10.1016/j.pharmthera.2006.10.001. Epub 2006 Oct 14. Pharmacol Ther. 2007. PMID: 17125841 Free PMC article. Review.

10

Arresting angiotensin type 1 receptors.

Thomas WG, Qian H. Thomas WG, et al. Trends Endocrinol Metab. 2003 Apr;14(3):130-6. doi: 10.1016/s1043-2760(03)00023-7. Trends Endocrinol Metab. 2003. PMID: 12670739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page